Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming-Reference-Cited by-同舟云学术

Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming

Published:2018-03-26 Issue: Volume: Page:e1456603
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Johnson Laura E.¹,Brockstedt Dirk²,Leong Meredith²,Lauer Peter²,Theisen Erin³,Sauer John-Demian³,McNeel Douglas G.¹

Affiliation:

1. University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI

2. Aduro Biotech, Inc., Berkeley, CA

3. Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI

Funder

U.S. Department of Defense (DOD)

HHS | National Institutes of Health (NIH)

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1456603

Reference50 articles.

1. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

2. DNA vaccines for prostate cancer

3. Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells

4. Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

5. Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking Immunity: Innovative prostate cancer vaccine strategies;International Immunopharmacology;2024-12

2. Exploiting bacteria for cancer immunotherapy;Nature Reviews Clinical Oncology;2024-06-05

3. Vaccines as treatments for prostate cancer;Nature Reviews Urology;2023-03-06

4. Plasmid DNA for Therapeutic Applications in Cancer;Pharmaceutics;2022-09-03

5. Immunotherapy: an alternative promising therapeutic approach against cancers;Molecular Biology Reports;2022-06-27